ADP-ribosylation of p53 tumor suppressor protein: Mutant but not wild- type p53 is modified

Journal of Cellular Biochemistry

Volumn 62, Issue 1, 1996, Pages 90-101

  Wȩsierska Ga̧dek, Jézefa ^a   Bugajska Schretter, Agnes ^a   Cerni, Christa ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

ADP ribosylation; p53 protein; rat cells; tumor suppressor protein

Indexed keywords

PROTEIN P53;

ADENOSINE DIPHOSPHATE RIBOSYLATION; ANIMAL CELL; ARTICLE; CELL TRANSFORMATION; CYTOLYSIS; EMBRYO; IMMUNOFLUORESCENCE MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN MODIFICATION; RAT;

EID: 0029843775     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(199607)62:1<90::AID-JCB10>3.0.CO;2-J     Document Type: Article

References (46)

1. Bayle JH, Elenbaas B, Levine AJ (1995): The carboxyl-terminal domain of the p53 protein regulates sequence-specific DNA binding through its nonspecific nucleic acid-binding activity. Proc Natl Acad Sci U S A 92:5729-5733.
2. Berger NA (1985): Poly(ADP-ribose) in the cellular response to DNA damage. Radiat Res 101:4-15.
3. Boulikas T (1991): Relation between carcinogenesis, chromatin structure and poly(ADP-ribosylation). (Review). Anticancer Res 11:489-528.
4. Burke B, Tooze J, Warren G (1983): A monoclonal antibody which recognises each of the nuclear lamin polypeptides in mammalian cells. EMBO J 2:361-367.
5. Cerni C, Patocka K, Meneguzzi G (1990): Immortalization of primary rat embryo cells by human papillomavirus type 11 DNA is enhanced upon cotransfer of ras. Virology 177:427-436.
6. Cox LS, Hupp T, Midgley CA, Lane DP (1995a): A direct effect of activated human p53 on nuclear replication. EMBO J 14:2099-2105.
7. Cox LS, Lane DP (1995b): Tumour suppressors, kinases and clamps: how p53 regulates the cell cycle in response to DNA damage. Bioessays 17:501-508.
8. Darby MK, Schmitt B, Jongstra-Bilen I, Vosberg HP (1985): Inhibition of calf thymus type II DNA topoisomerase by poly(ADP-ribosylation). EMBO J 4:2129-2134.
9. Donehower LA, Bradley A (1993): The tumor suppressor p53. Biochim Biophys Acta 1155:181-205.
10. Eliyahu D, Michalovitz D, Oren M (1985): Overproduction of p53 antigen makes established cells highly tumorigenic. Nature 316:158-160.
11. Eliyahu D, Evans S, Rosen N, Eliyahu S, Zwiebel J, Paik S, Lippman M (1994): p53vall35 temperature sensitive mutant suppresses growth of human breast cancer cells. Breast Cancer Research and Treatment 30:167-177.
12. Fakan S, Leduc Y, Lamarre D, Brunet G, Poirier GG (1988): Immunoelectron microscopical distribution of poly(ADP-ribose) polymerase in the mammalian cell nucleus. Exp Cell Res 179:517-526.
13. Ferro AM, Higgins NP, Olivera BM (1983): Poly(ADP-ribosylation) of a DNA topoisomerase. J Biol Chem 258: 6000-6003.
14. Fritsche M, Haessler C, Brandner G (1993): Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents. Oncogene 8:307-318.
15. Ganon JV, Lane DP (1991): Protein synthesis required to anchor a mutant p53 protein which is temperature-sensitive for nuclear transport. Nature 349:802-806.
16. Giner H, Simonin F, de Murcia G, Menissier-de Murcia J (1992): Overproduction and large-scale purification of the human poly(ADP-ribose) polymerase using a baculovirus expression system. Gene 114:279-283.
17. Gradwohl G, Mesnissier-de Murcia J, Molinette M, Simonin F, Koken M, Hoeijmakers JH, de Murcia G (1990): The second zinc-finger domain of poly(ADP-ribose) polymerase determines specificity for single-stranded breaks in DNA. Proc Natl Acad Sci U S A 87:2990-2994.
18. Hinds PW, Finlay CA, Frey AB, Levine AJ (1987): Immunological evidence for the association of p53 with a heat shock protein, hsc70, in p53-plus-ras-transformed cell lines. Mol Cell Biol 7:2863-2869.
19. Hollstein M, Sidransky D, Vogelstein B, and Harris CC (1991): p53 mutations in human cancers. Science 253:49-53.
20. Hsu Y-S, Tang F-M, Liu W-L, Chuang J-Y, Lai M-Y, Lin Y-S (1995): Transcriptional regulation by p53. Functional interaction among multiple regulatory domains. J Biol Chem 270:6966-6974.
21. Jongstra-Bilen J, Ittel ME, Niedergang C, Vosberg HP, Mandel P (1983): DNA topoisomerase I from calf thymus is inhibited in vitro by poly(ADP-ribosylation). Eur J Biochem 136:391-396.
22. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW (1991): Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51:6304-6311.
23. Laemmli UK (1970): Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
24. Land H, Parada LF, Weinberg RA (1983): Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 304:596-602.
25. Legros Y, Meyer A, Ory K, Soussi T (1994): Mutations in p53 produce a common conformational effect that can be detected with a panel of monoclonal antibodies directed toward the central part of the p53 protein. Oncogene 9:3689-3694.
26. Leitinger N, Wȩsierska-Ga̧dek J (1993): ADP-ribosylation of nucleolar proteins in HeLa tumor cells. J Cell Biochem 52:153-158.
27. 1 phase. Proc Natl Acad Sci U S A 89:9210-9214.
28. Meneguzzi G, Binetruy B, Cuzin F (1984): Plasmidal maintenance in rodent fibroblasts of BPV1-pBR322 shuttle vector without immediately apparent oncogenic transformation of the recipient cells. EMBO J 3:365-371.
29. Michalovitz D, Halevy O, Oren M (1990): Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53. Cell 62:671-680.
30. Momand J, Zambetti GP, Olson DC, George D, Levine AJ (1992): The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69:1237-1245.
31. Mosgoeller W, Steiner M, Hozak P, Penner E, Wȩsierska-Ga̧dek J (1996): Nuclear architecture and ultrastructural distribution of poly(ADP-ribosyl)transferase, a multifunctional enzyme. J Cell Sci 109:403-418.
32. de Murcia G, Menissier-de Murcia J, Schreiber V (1991): Poly(ADP-ribose)polymerase: molecular biological aspects. Bioessays 13:455-462.
33. Niedergang C, Okazaki H, Mandel P (1979): Properties of purified calf thymus poly(adenosine diphosphate ribose) polymerase, Comparison of the DNA-independent and the DNA-dependent enzyme. Eur J Biochem 102:43-57.
34. Oliner JD, Kinzler KW, Meltzer PS, George DL, Vogelstein B (1992): Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 358:80-83.
35. Pinhasi-Kimhi O, Michalovitz D, Ben-Zeev A, Oren M (1986): Specific interaction between the p53 cellular tumour antigen and major heat shock proteins. Nature 320:182-184.
36. Reich NC, Levine AJ (1984): Growth regulation of a cellular tumour antigen, p53 in nontransformed cells. Nature 308:199-201.
37. Shall S (1982): ADP-Ribose in DNA repair. In: Hayaishi O, Ueda K (eds): "ADP-Ribosylation Reactions," London, New York: Academic Press, pp 477-520.
38. Ueda K, Hayaishi O (1985): ADP-ribosylation. Annu Rev Biochem 54:73-100.
39. Ullrich SJ, Anderson CW, Mercer WE, Appella E (1992): The p53 tumor suppressor protein, a modulator of cell proliferation. J Biol Chem 267:15259-15262.
40. Ullrich SJ, Sakaguchi K, Lees-Miller SP, Fiscella M, Mercer WE, Anderson CW, Appella E (1993): Phosphorylation at ser-15 and ser-392 in mutant p53 molecules from human tumors is altered compared to wild-type p53. Proc Natl Acad Sci U S A 90:5954-5958.
41. Wȩsierska-Ga̧dek J, Sauermann G (1985): Modification of nuclear matrix proteins by ADP-ribosylation. Association of nuclear ADP-ribosyltransferase with the nuclear matrix. Eur J Biochem 153:421-428.
42. Wong M, Malik N, Smulson M (1982): The participation of poly(ADP-ribosyl)ated histone H1 in oligonucleosomal condensation. Eur J Biochem 128:209-213.
43. Yeargin Y, Haas M (1995): Elevated levels of wild-type p53 induced by radiolabeling of cells leads to apoptosis or sustained growth arrest. Curr Biol 5:423-431.
44. Yoshihara K, Itaya A, Tanaka Y, Ohashi Y, Ito K, Teraoka H, Tsukada K, Matsukage A, Kamiya T (1985): Inhibition of DNA polymerasea α, DNA polymerase β, terminal deoxy-nucleotidyl transferase, and DNA ligase II by poly(ADP-ribosyl)ation reaction in vitro. Biochem Biophys Res Commun 128:61-67.
45. Zambetti GP, Olson D, Labow M, Levine AJ (1992): A mutant p53 protein is required for maintenance of the transformed phenotype in cells transformed with p53 plus ras cDNAs. Proc Natl Acad Sci U S A 89:3952-3956.
46. Zhan Q, Carrier F, Fornace AJ, Jr (1993): Induction of cellular p53 activity by DNA-damaging agents and growth arrest. Mol Cell Biol 13:4242-4250.